Russian system of certification of new drugs are not always consistent with international standards, with the result that pharmacies offer customers a large number of drugs whose effectiveness has not been confirmed, and safety has not been proven.Thus, the drug "Arbidol", which is intended for the treatment and prevention of influenza, recommends itself Ministry of Health and Social Development of Russia.But does it really help?
The "Arbidol" there are many domestic and less expensive counterparts, which do an excellent job with the flu virus.
In terms of the current legislation, "Arbidol" is legal and completely safe.This drug is registered in Russia, and, thanks to a brilliant market
use of "Arbidol" abroad
In foreign countries, the sale of pharmaceuticals belong to the seriousness.No company can register a medicine that has not passed a series of clinical studies on the efficacy and safety.Such studies require large material costs, which subsequently have to pay back the quality of the drug.Therefore, in the rest of the world "Arbidol", which is a purely Russian drug does not produce and do not use.
In addition, all information about the quality of "Arbidol" comes exclusively from the manufacturer, which is an interested party.
neighboring countries use the analogy of "Arbidol" on the basis of the preparation - so in Belarus sell "Arpetol" in Ukraine - "Immustat" Russia itself is also popular "Remantadin", which is not inferior to "arbidol"efficacy, but differs in a lower price.Raw material for the manufacture of these products delivers the plant, which produced "Arbidol".
Other countries are widely used in place of "Arbidol" such as the antiviral drug "Tamiflu", which passed all the necessary clinical studies have confirmed its safety and efficacy - in contrast to the unpredictable Russian "Arbidol".